Skip to main content

Samuel Silver, MD

Supervisors: Dr. Chaim Bell and Dr. Glenn Chertow
Award: KRESCENT Fellowship
Institution: University of Toronto
Year: 2014-2017

Dr. Samuel Silver is a nephrologist who recently completed a M.Sc. in Quality Improvement (QI) and patient safety at the University of Toronto. This post-doctoral fellowship will support his formal training under the supervision of leaders in QI methods, (Dr. Chaim Bell, University of Toronto), and AKI/clinical trial research, (Dr. Glenn Chertow, Stanford University).

Acute Kidney Injury (AKI) is defined as a rapid decline in kidney function over a period of days. AKI survivors are at increased risk of developing Chronic Kidney Disease (CKD), yet only 25% of patients with AKI see a nephrologist within one year of discharge. While a nephrology fellow at the University of Toronto Dr. Silver led the development of a weekly AKI follow-up clinic at St Michael’s Hospital to assess AKI survivors within 30 days of discharge, the window when a patient is most vulnerable and the coordination of care is crucial. Dr. Silver’s research will test whether early follow-up after AKI can improve patient survival and reduce repeat AKI, CKD, chronic dialysis, cardiac events, and hospitalizations.